NPEPPS Human

Aminopeptidase Puromycin Sensitive Human Recombinant
Cat. No.
BT23588
Source

HEK293 Cells.

Synonyms

PSA, MP100, AAP-S, Puromycin-sensitive aminopeptidase, Cytosol alanyl aminopeptidase, aminopeptidase puromycin sensitive.

Appearance

Sterile filtered colorless solution.

Purity

Greater than 85.0% as determined by SDS-PAGE.

Usage

THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Shipped with Ice Packs
In Stock

Description

NPEPPS Human Recombinant produced in HEK293 Cells is a single, glycosylated polypeptide chain containing 925 amino acids (1-919 a.a.) and having a molecular mass of 104kDa. NPEPPS is fused to a 6 amino acid His-tag at C-terminus and is purified by proprietary chromatographic techniques.

Product Specs

Description
NPEPPS Human Recombinant produced in HEK293 Cells is a single, glycosylated polypeptide chain containing 925 amino acids (1-919 a.a.) and having a molecular mass of 104kDa. NPEPPS is fused to a 6 amino acid His-tag at C-terminus and is purified by proprietary chromatographic techniques.
Physical Appearance
Sterile filtered colorless solution.
Formulation
NPEPPS protein solution (0.25mg/ml) containing 20% Glycerol and Phosphate-Buffered Saline (pH 7.4).
Stability
Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid multiple freeze-thaw cycles.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Biological Activity
Specific activity is > 800 pmol/min/ug and is defined as the amount of enzyme that cleaves 1 pmole of H-Leu[1]AMC per minute at pH 7.0 at 37°C.
Synonyms

PSA, MP100, AAP-S, Puromycin-sensitive aminopeptidase, Cytosol alanyl aminopeptidase, aminopeptidase puromycin sensitive.

Source

HEK293 Cells.

Amino Acid Sequence

MWLAAAAPSL ARRLLFLGPP PPPLLLLVFS RSSRRRLHSL GLAAMPEKRP FERLPADVSP INYSLCLKPD LLDFTFEGKL EAAAQVRQAT NQIVMNCADI DIITASYAPE GDEEIHATGF NYQNEDEKVT LSFPSTLQTG TGTLKIDFVG ELNDKMKGFY RSKYTTPSGE VRYAAVTQFE ATDARRAFPC WDEPAIKATF DISLVVPKDR VALSNMNVID RKPYPDDENL VEVKFARTPV MSTYLVAFVV GEYDFVETRS KDGVCVRVYT PVGKAEQGKF ALEVAAKTLP FYKDYFNVPY PLPKIDLIAI ADFAAGAMEN GLVTYRETA LLIDPKNSCS SSRQWVALVV GHELAHQWFG NLVTMEWWTH LWLNEGFASW IEYLCVDHCF PEYDIWTQFV SADYTRAQEL DALDNSHPIE VSVGHPSEVD EIFDAISYSK GASVIRMLHD YIGDKDFKKG MNMYLTKFQQ KNAATEDLWE SLENASGKPI AAVMNTWTKQ MGFPLIYVEA EQVEDDRLLR LSQKKFCAGG SYVGEDCPQW MVPITISTSE DPNQAKLKIL MDKPEMNVVL KNVKPDQWVK LNLGTVGFYR TQYSSAMLES LLPGIRDLSL PPVDRLGLQN DLFSLARAGI ISTVEVLKVM EAFVNEPNYT VWSDLSCNLG  ILSTLLSHTD FYEEIQEFVK DVFSPIGERL GWDPKPGEGH LDALLRGLVL GKLGKAGHKA TLEEARRRFK DHVEGKQILS ADLRSPVYLT VLKHGDGTTL DIMLKLHKQA DMQEEKNRIE RVLGATLLPD LIQKVLTFAL SEEVRPQDTV SVIGGVAGGS KHGRKAAWKF IKDNWEELYN RYQGGFLISR LIKLSVEGFA VDKMAGEVKA FFESHPAPSA ERTIQQCCEN ILLNAAWLKR DAESIHQYLL QRKASPPTVH HHHHH.

Product Science Overview

Biological Function and Importance

PSA/NPEPPS is involved in several biological processes, including:

  • Protein Degradation: It helps in the breakdown of proteins by removing amino acids from the N-terminus of peptide chains .
  • Antigen Processing: It plays a role in the Class I MHC-mediated antigen processing and presentation pathway .
  • Neuroprotection: PSA/NPEPPS has been identified as a novel modifier of TAU-induced neurodegeneration. It exhibits neuroprotective effects by directly proteolyzing TAU protein, which is implicated in neurodegenerative diseases such as Alzheimer’s disease .
Recombinant Human PSA/NPEPPS

Recombinant human PSA/NPEPPS is produced using baculovirus expression systems in insect cells (Spodoptera frugiperda, Sf 21) . The recombinant protein is typically supplied as a carrier-free formulation to avoid interference from other proteins like Bovine Serum Albumin (BSA) .

Specifications:

  • Purity: Greater than 90% as determined by SDS-PAGE under reducing conditions .
  • Activity: Measured by its ability to cleave the fluorogenic peptide substrate, Leu-AMC, with a specific activity of over 2,500 pmol/min/μg .
  • Molecular Mass: Predicted to be around 100 kDa .
Research and Therapeutic Potential

PSA/NPEPPS has been studied for its potential therapeutic applications, particularly in neurodegenerative diseases. Overexpression of PSA/NPEPPS in transgenic mouse models has shown to delay paralysis and improve motor neuron counts by reducing the levels of hyperphosphorylated TAU protein . This suggests that increasing PSA/NPEPPS activity could be a feasible therapeutic approach to eliminate the accumulation of toxic substrates like TAU .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.